CLINICAL_TRIALS
trial_result
· 2012-06-26
Clinical Trial Update: Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease [Phase 3]
Summary
A Phase 3 trial comparing pantoprazole magnesium 40 mg to esomeprazole 40 mg in patients with erosive gastroesophageal reflux disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: GERD | Phase 3 | Status: COMPLETED